世界のサルブタモール注射市場予測 2023年-2029年

【英語タイトル】Global Salbutamol Injection Market Growth 2023-2029

・商品コード：LP23DC00909
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥519,720	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥779,580	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,039,440	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のサルブタモール注射市場」は、過去の販売実績から2022年の世界のサルブタモール注射の総販売量を検討し、2023年から2029年の予測されるサルブタモール注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のサルブタモール注射の市場規模を掲載し、XXX百万米ドル規模の世界のサルブタモール注射市場の詳細な分析を提供します。本インサイトレポートは、世界のサルブタモール注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のサルブタモール注射市場における各社の独自のポジションをより深く理解するために、サルブタモール注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のサルブタモール注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。サルブタモール注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。サルブタモール注射の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。サルブタモール注射のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

サルブタモール注射の世界主要メーカーとしては、Teva Pharmaceuticals、 Mylan、 Novartis、 Pfizer、 Sanofi、 Merck、 Johnson & Johnson、 Roche、 GlaxoSmithKline、 AstraZeneca、 Abbott Laboratoriesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のサルブタモール注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではサルブタモール注射市場をセグメンテーションし、種類別 (サルブタモール硫酸塩注射液、サルブタモール＆臭化イプラトロピウム注射液)、用途別 (病院、専門クリニック、治療院、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：サルブタモール硫酸塩注射液、サルブタモール＆臭化イプラトロピウム注射液

・用途別区分：病院、専門クリニック、治療院、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のサルブタモール注射市場の10年間の市場状況・展望は？
・世界および地域別に見たサルブタモール注射市場成長の要因は何か？
・サルブタモール注射の市場機会はエンドマーケットの規模によってどのように変化するのか？
・サルブタモール注射のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：サルブタモール注射の年間販売量2018-2029、地域別現状・将来分析
・サルブタモール注射の種類別セグメント：サルブタモール硫酸塩注射液、サルブタモール＆臭化イプラトロピウム注射液
・サルブタモール注射の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・サルブタモール注射の用途別セグメント：病院、専門クリニック、治療院、その他
・サルブタモール注射の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のサルブタモール注射市場
・企業別のグローバルサルブタモール注射市場データ：2018-2023年の年間販売量、市場シェア
・企業別のサルブタモール注射の年間売上：2018-2023年の売上、市場シェア
・企業別のサルブタモール注射販売価格
・主要企業のサルブタモール注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

サルブタモール注射の地域別レビュー
・地域別のサルブタモール注射市場規模2018-2023：年間販売量、売上
・主要国別のサルブタモール注射市場規模2018-2023：年間販売量、売上
・南北アメリカのサルブタモール注射販売の成長
・アジア太平洋のサルブタモール注射販売の成長
・ヨーロッパのサルブタモール注射販売の成長
・中東・アフリカのサルブタモール注射販売の成長

南北アメリカ市場
・南北アメリカの国別のサルブタモール注射販売量、売上（2018-2023）
・南北アメリカのサルブタモール注射の種類別販売量
・南北アメリカのサルブタモール注射の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のサルブタモール注射販売量、売上（2018-2023）
・アジア太平洋のサルブタモール注射の種類別販売量
・アジア太平洋のサルブタモール注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のサルブタモール注射販売量、売上（2018-2023）
・ヨーロッパのサルブタモール注射の種類別販売量
・ヨーロッパのサルブタモール注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のサルブタモール注射販売量、売上（2018-2023）
・中東・アフリカのサルブタモール注射の種類別販売量
・中東・アフリカのサルブタモール注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・サルブタモール注射の製造コスト構造分析
・サルブタモール注射の製造プロセス分析
・サルブタモール注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・サルブタモール注射の主要なグローバル販売業者
・サルブタモール注射の主要なグローバル顧客

地域別のサルブタモール注射市場予測レビュー
・地域別のサルブタモール注射市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・サルブタモール注射の種類別市場規模予測
・サルブタモール注射の用途別市場規模予測

主要企業分析
Teva Pharmaceuticals、 Mylan、 Novartis、 Pfizer、 Sanofi、 Merck、 Johnson & Johnson、 Roche、 GlaxoSmithKline、 AstraZeneca、 Abbott Laboratories
・企業情報
・サルブタモール注射製品
・サルブタモール注射販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Salbutamol Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Salbutamol Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Salbutamol Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Salbutamol Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Salbutamol Injection players cover Teva Pharmaceuticals, Mylan, Novartis, Pfizer, Sanofi, Merck, Johnson & Johnson, Roche and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Salbutamol Injection Industry Forecast” looks at past sales and reviews total world Salbutamol Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Salbutamol Injection sales for 2023 through 2029. With Salbutamol Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Salbutamol Injection industry.
This Insight Report provides a comprehensive analysis of the global Salbutamol Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Salbutamol Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Salbutamol Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Salbutamol Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Salbutamol Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Salbutamol Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Salbutamol Sulfate Injection
Salbutamol and Ipratropium Bromide Injection
Segmentation by application
Hospital
Specialty Clinic
Treatment Center
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Teva Pharmaceuticals
Mylan
Novartis
Pfizer
Sanofi
Merck
Johnson & Johnson
Roche
GlaxoSmithKline
AstraZeneca
Abbott Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global Salbutamol Injection market?
What factors are driving Salbutamol Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Salbutamol Injection market opportunities vary by end market size?
How does Salbutamol Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Salbutamol Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Salbutamol Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Salbutamol Injection by Country/Region, 2018, 2022 & 2029
2.2 Salbutamol Injection Segment by Type
2.2.1 Salbutamol Sulfate Injection
2.2.2 Salbutamol and Ipratropium Bromide Injection
2.3 Salbutamol Injection Sales by Type
2.3.1 Global Salbutamol Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Salbutamol Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Salbutamol Injection Sale Price by Type (2018-2023)
2.4 Salbutamol Injection Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Treatment Center
2.4.4 Others
2.5 Salbutamol Injection Sales by Application
2.5.1 Global Salbutamol Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Salbutamol Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Salbutamol Injection Sale Price by Application (2018-2023)
3 Global Salbutamol Injection by Company
3.1 Global Salbutamol Injection Breakdown Data by Company
3.1.1 Global Salbutamol Injection Annual Sales by Company (2018-2023)
3.1.2 Global Salbutamol Injection Sales Market Share by Company (2018-2023)
3.2 Global Salbutamol Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Salbutamol Injection Revenue by Company (2018-2023)
3.2.2 Global Salbutamol Injection Revenue Market Share by Company (2018-2023)
3.3 Global Salbutamol Injection Sale Price by Company
3.4 Key Manufacturers Salbutamol Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Salbutamol Injection Product Location Distribution
3.4.2 Players Salbutamol Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Salbutamol Injection by Geographic Region
4.1 World Historic Salbutamol Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Salbutamol Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Salbutamol Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Salbutamol Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Salbutamol Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Salbutamol Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Salbutamol Injection Sales Growth
4.4 APAC Salbutamol Injection Sales Growth
4.5 Europe Salbutamol Injection Sales Growth
4.6 Middle East & Africa Salbutamol Injection Sales Growth
5 Americas
5.1 Americas Salbutamol Injection Sales by Country
5.1.1 Americas Salbutamol Injection Sales by Country (2018-2023)
5.1.2 Americas Salbutamol Injection Revenue by Country (2018-2023)
5.2 Americas Salbutamol Injection Sales by Type
5.3 Americas Salbutamol Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Salbutamol Injection Sales by Region
6.1.1 APAC Salbutamol Injection Sales by Region (2018-2023)
6.1.2 APAC Salbutamol Injection Revenue by Region (2018-2023)
6.2 APAC Salbutamol Injection Sales by Type
6.3 APAC Salbutamol Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Salbutamol Injection by Country
7.1.1 Europe Salbutamol Injection Sales by Country (2018-2023)
7.1.2 Europe Salbutamol Injection Revenue by Country (2018-2023)
7.2 Europe Salbutamol Injection Sales by Type
7.3 Europe Salbutamol Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Salbutamol Injection by Country
8.1.1 Middle East & Africa Salbutamol Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Salbutamol Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Salbutamol Injection Sales by Type
8.3 Middle East & Africa Salbutamol Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Salbutamol Injection
10.3 Manufacturing Process Analysis of Salbutamol Injection
10.4 Industry Chain Structure of Salbutamol Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Salbutamol Injection Distributors
11.3 Salbutamol Injection Customer
12 World Forecast Review for Salbutamol Injection by Geographic Region
12.1 Global Salbutamol Injection Market Size Forecast by Region
12.1.1 Global Salbutamol Injection Forecast by Region (2024-2029)
12.1.2 Global Salbutamol Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Salbutamol Injection Forecast by Type
12.7 Global Salbutamol Injection Forecast by Application
13 Key Players Analysis
13.1 Teva Pharmaceuticals
13.1.1 Teva Pharmaceuticals Company Information
13.1.2 Teva Pharmaceuticals Salbutamol Injection Product Portfolios and Specifications
13.1.3 Teva Pharmaceuticals Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceuticals Main Business Overview
13.1.5 Teva Pharmaceuticals Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Salbutamol Injection Product Portfolios and Specifications
13.2.3 Mylan Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Salbutamol Injection Product Portfolios and Specifications
13.3.3 Novartis Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Salbutamol Injection Product Portfolios and Specifications
13.4.3 Pfizer Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Salbutamol Injection Product Portfolios and Specifications
13.5.3 Sanofi Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Salbutamol Injection Product Portfolios and Specifications
13.6.3 Merck Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Salbutamol Injection Product Portfolios and Specifications
13.7.3 Johnson & Johnson Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Roche
13.8.1 Roche Company Information
13.8.2 Roche Salbutamol Injection Product Portfolios and Specifications
13.8.3 Roche Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Roche Main Business Overview
13.8.5 Roche Latest Developments
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Information
13.9.2 GlaxoSmithKline Salbutamol Injection Product Portfolios and Specifications
13.9.3 GlaxoSmithKline Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GlaxoSmithKline Main Business Overview
13.9.5 GlaxoSmithKline Latest Developments
13.10 AstraZeneca
13.10.1 AstraZeneca Company Information
13.10.2 AstraZeneca Salbutamol Injection Product Portfolios and Specifications
13.10.3 AstraZeneca Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 AstraZeneca Main Business Overview
13.10.5 AstraZeneca Latest Developments
13.11 Abbott Laboratories
13.11.1 Abbott Laboratories Company Information
13.11.2 Abbott Laboratories Salbutamol Injection Product Portfolios and Specifications
13.11.3 Abbott Laboratories Salbutamol Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Abbott Laboratories Main Business Overview
13.11.5 Abbott Laboratories Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Salbutamol Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Salbutamol Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Salbutamol Sulfate Injection
Table 4. Major Players of Salbutamol and Ipratropium Bromide Injection
Table 5. Global Salbutamol Injection Sales by Type (2018-2023) & (K Units)
Table 6. Global Salbutamol Injection Sales Market Share by Type (2018-2023)
Table 7. Global Salbutamol Injection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Salbutamol Injection Revenue Market Share by Type (2018-2023)
Table 9. Global Salbutamol Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Salbutamol Injection Sales by Application (2018-2023) & (K Units)
Table 11. Global Salbutamol Injection Sales Market Share by Application (2018-2023)
Table 12. Global Salbutamol Injection Revenue by Application (2018-2023)
Table 13. Global Salbutamol Injection Revenue Market Share by Application (2018-2023)
Table 14. Global Salbutamol Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Salbutamol Injection Sales by Company (2018-2023) & (K Units)
Table 16. Global Salbutamol Injection Sales Market Share by Company (2018-2023)
Table 17. Global Salbutamol Injection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Salbutamol Injection Revenue Market Share by Company (2018-2023)
Table 19. Global Salbutamol Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Salbutamol Injection Producing Area Distribution and Sales Area
Table 21. Players Salbutamol Injection Products Offered
Table 22. Salbutamol Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Salbutamol Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Salbutamol Injection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Salbutamol Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Salbutamol Injection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Salbutamol Injection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Salbutamol Injection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Salbutamol Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Salbutamol Injection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Salbutamol Injection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Salbutamol Injection Sales Market Share by Country (2018-2023)
Table 35. Americas Salbutamol Injection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Salbutamol Injection Revenue Market Share by Country (2018-2023)
Table 37. Americas Salbutamol Injection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Salbutamol Injection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Salbutamol Injection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Salbutamol Injection Sales Market Share by Region (2018-2023)
Table 41. APAC Salbutamol Injection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Salbutamol Injection Revenue Market Share by Region (2018-2023)
Table 43. APAC Salbutamol Injection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Salbutamol Injection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Salbutamol Injection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Salbutamol Injection Sales Market Share by Country (2018-2023)
Table 47. Europe Salbutamol Injection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Salbutamol Injection Revenue Market Share by Country (2018-2023)
Table 49. Europe Salbutamol Injection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Salbutamol Injection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Salbutamol Injection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Salbutamol Injection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Salbutamol Injection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Salbutamol Injection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Salbutamol Injection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Salbutamol Injection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Salbutamol Injection
Table 58. Key Market Challenges & Risks of Salbutamol Injection
Table 59. Key Industry Trends of Salbutamol Injection
Table 60. Salbutamol Injection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Salbutamol Injection Distributors List
Table 63. Salbutamol Injection Customer List
Table 64. Global Salbutamol Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Salbutamol Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Salbutamol Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Salbutamol Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Salbutamol Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Salbutamol Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Salbutamol Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Salbutamol Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Salbutamol Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Salbutamol Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Salbutamol Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Salbutamol Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Salbutamol Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Salbutamol Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Teva Pharmaceuticals Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharmaceuticals Salbutamol Injection Product Portfolios and Specifications
Table 80. Teva Pharmaceuticals Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Teva Pharmaceuticals Main Business
Table 82. Teva Pharmaceuticals Latest Developments
Table 83. Mylan Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Mylan Salbutamol Injection Product Portfolios and Specifications
Table 85. Mylan Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Mylan Main Business
Table 87. Mylan Latest Developments
Table 88. Novartis Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Salbutamol Injection Product Portfolios and Specifications
Table 90. Novartis Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Pfizer Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Salbutamol Injection Product Portfolios and Specifications
Table 95. Pfizer Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Sanofi Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Salbutamol Injection Product Portfolios and Specifications
Table 100. Sanofi Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Merck Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Salbutamol Injection Product Portfolios and Specifications
Table 105. Merck Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Johnson & Johnson Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Johnson & Johnson Salbutamol Injection Product Portfolios and Specifications
Table 110. Johnson & Johnson Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Johnson & Johnson Main Business
Table 112. Johnson & Johnson Latest Developments
Table 113. Roche Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Roche Salbutamol Injection Product Portfolios and Specifications
Table 115. Roche Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Roche Main Business
Table 117. Roche Latest Developments
Table 118. GlaxoSmithKline Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. GlaxoSmithKline Salbutamol Injection Product Portfolios and Specifications
Table 120. GlaxoSmithKline Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. GlaxoSmithKline Main Business
Table 122. GlaxoSmithKline Latest Developments
Table 123. AstraZeneca Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. AstraZeneca Salbutamol Injection Product Portfolios and Specifications
Table 125. AstraZeneca Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. AstraZeneca Main Business
Table 127. AstraZeneca Latest Developments
Table 128. Abbott Laboratories Basic Information, Salbutamol Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Abbott Laboratories Salbutamol Injection Product Portfolios and Specifications
Table 130. Abbott Laboratories Salbutamol Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Abbott Laboratories Main Business
Table 132. Abbott Laboratories Latest Developments
List of Figures
Figure 1. Picture of Salbutamol Injection
Figure 2. Salbutamol Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Salbutamol Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Salbutamol Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Salbutamol Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Salbutamol Sulfate Injection
Figure 10. Product Picture of Salbutamol and Ipratropium Bromide Injection
Figure 11. Global Salbutamol Injection Sales Market Share by Type in 2022
Figure 12. Global Salbutamol Injection Revenue Market Share by Type (2018-2023)
Figure 13. Salbutamol Injection Consumed in Hospital
Figure 14. Global Salbutamol Injection Market: Hospital (2018-2023) & (K Units)
Figure 15. Salbutamol Injection Consumed in Specialty Clinic
Figure 16. Global Salbutamol Injection Market: Specialty Clinic (2018-2023) & (K Units)
Figure 17. Salbutamol Injection Consumed in Treatment Center
Figure 18. Global Salbutamol Injection Market: Treatment Center (2018-2023) & (K Units)
Figure 19. Salbutamol Injection Consumed in Others
Figure 20. Global Salbutamol Injection Market: Others (2018-2023) & (K Units)
Figure 21. Global Salbutamol Injection Sales Market Share by Application (2022)
Figure 22. Global Salbutamol Injection Revenue Market Share by Application in 2022
Figure 23. Salbutamol Injection Sales Market by Company in 2022 (K Units)
Figure 24. Global Salbutamol Injection Sales Market Share by Company in 2022
Figure 25. Salbutamol Injection Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Salbutamol Injection Revenue Market Share by Company in 2022
Figure 27. Global Salbutamol Injection Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Salbutamol Injection Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Salbutamol Injection Sales 2018-2023 (K Units)
Figure 30. Americas Salbutamol Injection Revenue 2018-2023 ($ Millions)
Figure 31. APAC Salbutamol Injection Sales 2018-2023 (K Units)
Figure 32. APAC Salbutamol Injection Revenue 2018-2023 ($ Millions)
Figure 33. Europe Salbutamol Injection Sales 2018-2023 (K Units)
Figure 34. Europe Salbutamol Injection Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Salbutamol Injection Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Salbutamol Injection Revenue 2018-2023 ($ Millions)
Figure 37. Americas Salbutamol Injection Sales Market Share by Country in 2022
Figure 38. Americas Salbutamol Injection Revenue Market Share by Country in 2022
Figure 39. Americas Salbutamol Injection Sales Market Share by Type (2018-2023)
Figure 40. Americas Salbutamol Injection Sales Market Share by Application (2018-2023)
Figure 41. United States Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Salbutamol Injection Sales Market Share by Region in 2022
Figure 46. APAC Salbutamol Injection Revenue Market Share by Regions in 2022
Figure 47. APAC Salbutamol Injection Sales Market Share by Type (2018-2023)
Figure 48. APAC Salbutamol Injection Sales Market Share by Application (2018-2023)
Figure 49. China Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Salbutamol Injection Sales Market Share by Country in 2022
Figure 57. Europe Salbutamol Injection Revenue Market Share by Country in 2022
Figure 58. Europe Salbutamol Injection Sales Market Share by Type (2018-2023)
Figure 59. Europe Salbutamol Injection Sales Market Share by Application (2018-2023)
Figure 60. Germany Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Salbutamol Injection Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Salbutamol Injection Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Salbutamol Injection Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Salbutamol Injection Sales Market Share by Application (2018-2023)
Figure 69. Egypt Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Salbutamol Injection Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Salbutamol Injection in 2022
Figure 75. Manufacturing Process Analysis of Salbutamol Injection
Figure 76. Industry Chain Structure of Salbutamol Injection
Figure 77. Channels of Distribution
Figure 78. Global Salbutamol Injection Sales Market Forecast by Region (2024-2029)
Figure 79. Global Salbutamol Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Salbutamol Injection Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Salbutamol Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Salbutamol Injection Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Salbutamol Injection Revenue Market Share Forecast by Application (2024-2029)

★調査レポート[世界のサルブタモール注射市場予測 2023年-2029年] (コード：LP23DC00909)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のサルブタモール注射市場予測 2023年-2029年]についてメールでお問い合わせ

カテゴリー：世界, 医療/バイオ, LP Information

世界のサルブタモール注射市場予測 2023年-2029年

【英語タイトル】Global Salbutamol Injection Market Growth 2023-2029

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥519,720	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥779,580	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,039,440	見積依頼/購入/質問フォーム

❖ レポートの概要 ❖

❖ レポートの目次 ❖

★調査レポート[世界のサルブタモール注射市場予測 2023年-2029年] (コード：LP23DC00909)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のサルブタモール注射市場予測 2023年-2029年]についてメールでお問い合わせ

◆H&Iグローバルリサーチのお客様（例）◆

MarketReport.jp

世界のサルブタモール注射市場予測 2023年-2029年

世界のサルブタモール注射市場予測 2023年-2029年

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp